Moreover, the clinical significance of MPDZ expression in ccRCC patients was assessed by performing a meta-analysis of the association of MPDZ gene expression with outcomes among ccRCC patients. This evidence concerns the gene MPDZ and nonpapillary renal cell carcinoma.